$RGEN
REPLIGEN CORP

2015 Q3 Form 10-Q Financial Statement

#000119312515368180 Filed on November 05, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q3
Revenue $19.81M $15.28M
YoY Change 29.69% -18.83%
Cost Of Revenue $8.444M $6.931M
YoY Change 21.83% 22.48%
Gross Profit $11.37M $8.347M
YoY Change 36.22% -36.59%
Gross Profit Margin 57.38% 54.63%
Selling, General & Admin $5.959M $4.471M
YoY Change 33.28% 54.07%
% of Gross Profit 52.41% 53.56%
Research & Development $1.490M $1.650M
YoY Change -9.7% 15.38%
% of Gross Profit 13.1% 19.77%
Depreciation & Amortization $1.150M $1.100M
YoY Change 4.55% 44.74%
% of Gross Profit 10.11% 13.18%
Operating Expenses $7.449M $6.121M
YoY Change 21.7% 41.3%
Operating Profit $3.688M $2.216M
YoY Change 66.43% -72.44%
Interest Expense $8.000K $11.00K
YoY Change -27.27% -6.02%
% of Operating Profit 0.22% 0.5%
Other Income/Expense, Net -$38.00K -$14.00K
YoY Change 171.43% -137.84%
Pretax Income $3.679M $2.255M
YoY Change 63.15% -72.31%
Income Tax $1.141M $789.0K
% Of Pretax Income 31.01% 34.99%
Net Earnings $2.538M $1.466M
YoY Change 73.12% -75.1%
Net Earnings / Revenue 12.81% 9.6%
Basic Earnings Per Share $0.08 $0.04
Diluted Earnings Per Share $0.08 $0.04
COMMON SHARES
Basic Shares Outstanding 32.93M shares 32.68M shares
Diluted Shares Outstanding 33.69M shares 33.33M shares

Balance Sheet

Concept 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.90M $54.10M
YoY Change 27.36% -14.13%
Cash & Equivalents $48.08M $35.91M
Short-Term Investments $20.80M $18.20M
Other Short-Term Assets $1.100M $1.200M
YoY Change -8.33% -20.0%
Inventory $15.90M $13.34M
Prepaid Expenses
Receivables $10.32M $7.053M
Other Receivables $100.0K $0.00
Total Short-Term Assets $96.28M $75.69M
YoY Change 27.2% -13.44%
LONG-TERM ASSETS
Property, Plant & Equipment $13.97M $13.19M
YoY Change 5.93% 7.32%
Goodwill $14.35M $14.14M
YoY Change 1.43% 1322.94%
Intangibles $13.15M $15.35M
YoY Change -14.3% 136.8%
Long-Term Investments $1.700M $10.00M
YoY Change -83.0% 143.9%
Other Assets $500.0K $500.0K
YoY Change 0.0% 66.67%
Total Long-Term Assets $43.57M $53.14M
YoY Change -18.0% 119.63%
TOTAL ASSETS
Total Short-Term Assets $96.28M $75.69M
Total Long-Term Assets $43.57M $53.14M
Total Assets $139.9M $128.8M
YoY Change 8.55% 15.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.951M $2.763M
YoY Change 6.81% 197.2%
Accrued Expenses $12.76M $7.708M
YoY Change 65.51% -1.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.71M $10.47M
YoY Change 50.03% 19.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.693M $3.688M
YoY Change -26.97% 36.8%
Total Long-Term Liabilities $2.693M $3.688M
YoY Change -26.97% 36.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.71M $10.47M
Total Long-Term Liabilities $2.693M $3.688M
Total Liabilities $18.40M $14.16M
YoY Change 29.97% 23.33%
SHAREHOLDERS EQUITY
Retained Earnings -$71.81M -$80.49M
YoY Change -10.79% -12.88%
Common Stock $202.0M $327.0K
YoY Change 61663.56% 2.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $121.5M $114.6M
YoY Change
Total Liabilities & Shareholders Equity $139.9M $128.8M
YoY Change 8.55% 15.4%

Cashflow Statement

Concept 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $2.538M $1.466M
YoY Change 73.12% -75.1%
Depreciation, Depletion And Amortization $1.150M $1.100M
YoY Change 4.55% 44.74%
Cash From Operating Activities $6.590M $6.330M
YoY Change 4.11% -3.8%
INVESTING ACTIVITIES
Capital Expenditures -$320.0K -$1.740M
YoY Change -81.61% -34.59%
Acquisitions
YoY Change
Other Investing Activities $1.930M $20.00K
YoY Change 9550.0% -96.67%
Cash From Investing Activities $1.620M -$1.720M
YoY Change -194.19% -16.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 240.0K -460.0K
YoY Change -152.17% 170.59%
NET CHANGE
Cash From Operating Activities 6.590M 6.330M
Cash From Investing Activities 1.620M -1.720M
Cash From Financing Activities 240.0K -460.0K
Net Change In Cash 8.450M 4.150M
YoY Change 103.61% -4.38%
FREE CASH FLOW
Cash From Operating Activities $6.590M $6.330M
Capital Expenditures -$320.0K -$1.740M
Free Cash Flow $6.910M $8.070M
YoY Change -14.37% -12.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
184000
CY2014Q2 us-gaap Goodwill
Goodwill
13352000
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
26540000
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
85000
CY2014Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1370000
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
431000
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
1003000
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
1647000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1259317 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.61
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35907000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1186665 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1252356 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2454573 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.33
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2015Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
682339 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32943553 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q3 us-gaap Share Price
SharePrice
27.85
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
504326 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.47
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.47
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32943553 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
14 Investment
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
201000
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
394000
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1082000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1482000
CY2015Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1589000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15709000
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3767000
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15748000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1371000
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12758000
CY2015Q3 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
0
CY2015Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
328000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
586000
CY2015Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4454000
CY2015Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
948000
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4485000
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
329000
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
201657000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
52000
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2044000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1888000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2693000
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
524000
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8728000
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71807000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
121451000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
139853000
CY2015Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2015Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4819000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2951000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2343000
CY2015Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
22441000
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
450000
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13154000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
1539000
CY2015Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4119000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13973000
CY2015Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1651000
CY2015Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2722000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
96279000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
22287000
CY2015Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
228000
CY2015Q3 us-gaap Goodwill
Goodwill
14346000
CY2015Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
20782000
CY2015Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8795000
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5000
CY2015Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
4920000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
21146000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
20790000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
1703000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
1202000
CY2015Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7455000
CY2015Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
13258000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48084000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
1524000
CY2015Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
10853000
CY2015Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2985000
CY2015Q3 us-gaap Assets
Assets
139853000
CY2015Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
17639000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
443000
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1123000
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10321000
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29721000
CY2015Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
57000
CY2015Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1000
CY2015Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
20790000
CY2015Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
22431000
CY2015Q3 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
0
CY2015Q3 us-gaap Inventory Net
InventoryNet
15899000
CY2015Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
13513000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
1703000
CY2015Q3 rgen Available For Sale Securities Debt Maturities One Through Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesOneThroughTwoYearsAmortizedCost
1649000
CY2015Q3 rgen Impact Of Credit Risk On Fair Value Of Derivatives
ImpactOfCreditRiskOnFairValueOfDerivatives
0
CY2015Q3 rgen Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
1651000
CY2015Q3 rgen Operating Leases Future Minimum Payments Due In Five Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter
3386000
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32943553 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39830000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1225117 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32774374 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.31
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32774374 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
571000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10682000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3759000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13816000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6819000
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
78000
CY2014Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1135000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3444000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
328000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
198064000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
41000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2081000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5879000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5773000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
511000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
713000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80887000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
111732000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128293000
CY2014Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000
CY2014Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3844000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3863000
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
26640000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
450000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14636000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4754000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14526000
CY2014Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
3550000
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2270000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
80946000
CY2014Q4 us-gaap Goodwill
Goodwill
14185000
CY2014Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9000
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5374000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5000
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
9108000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35363000
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2256000
CY2014Q4 us-gaap Assets
Assets
128293000
CY2014Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
18080000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2104000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7760000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28342000
CY2014Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
240000
CY2014Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3848000
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
23090000
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
26643000
CY2014Q4 us-gaap Inventory Net
InventoryNet
12384000
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
13116000
CY2014Q2 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
4000000
CY2014Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
21170000
CY2014Q2 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
26540000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
289475 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32292588 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.214 pure
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
16648000
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.28
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33099599 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.29
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
807011 shares
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-6678000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3852000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2964000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
54000
us-gaap Operating Income Loss
OperatingIncomeLoss
10630000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1347000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10896000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3000
us-gaap Revenues
Revenues
47155000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
763000
us-gaap Investment Income Net
InvestmentIncomeNet
250000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
45038000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
604000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-88000
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
us-gaap Net Income Loss
NetIncomeLoss
8569000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
9890000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
46000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
24236000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
21236000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1023000
us-gaap Royalty Revenue
RoyaltyRevenue
2117000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4763000
us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
250000
us-gaap Income Taxes Paid
IncomeTaxesPaid
671000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
50937000
us-gaap Interest Expense
InterestExpense
38000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2884000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2965000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
882000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2327000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
30117000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
126000
us-gaap Costs And Expenses
CostsAndExpenses
36525000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
261000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3923000
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
921000
us-gaap Share Based Compensation
ShareBasedCompensation
1386000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12180000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1984000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18569000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
19938000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1486000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4281000
rgen Increase Decrease In Noncurrent Liabilities
IncreaseDecreaseInNoncurrentLiabilities
-255000
dei Document Type
DocumentType
10-Q
dei Trading Symbol
TradingSymbol
RGEN
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
270532 shares
dei Entity Central Index Key
EntityCentralIndexKey
0000730272
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
170891 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.12
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y11M19D
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.57
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32860382 shares
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.258 pure
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
11701000
dei Amendment Flag
AmendmentFlag
false
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
71400 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.24
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
171893 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
22.41
dei Entity Registrant Name
EntityRegistrantName
REPLIGEN CORP
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y29D
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33617999 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y15D
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
757617 shares
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>1. Basis of Presentation</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The consolidated financial statements included herein have been prepared by Repligen Corporation (the &#x201C;Company,&#x201D; &#x201C;Repligen&#x201D; or &#x201C;we&#x201D;) in accordance with generally accepted accounting principles in the United States (&#x201C;U.S. GAAP&#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;), for Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X and do not include all of the information and footnote disclosures required by U.S. GAAP. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#xA0;31, 2014.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the entire year.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b><i>Recently Issued Accounting Pronouncements</i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> In May 2014, the Financial Accounting Standards Board (&#x201C;FASB&#x201D;) issued Accounting Standards Update (&#x201C;ASU&#x201D;) No.&#xA0;2014-09, which amends the guidance for accounting for revenue from contracts with customers. This ASU supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605, <i>Revenue Recognition</i>, and creates a new Topic 606, <i>Revenue from Contracts with Customers</i>. This guidance is effective for fiscal years beginning after December&#xA0;15, 2017, with early adoption permitted in fiscal years beginning after December&#xA0;15, 2016. Two adoption methods are permitted: retrospectively to all prior reporting periods presented, with certain practical expedients permitted; or retrospectively with the cumulative effect of initially adopting the ASU recognized at the date of initial application. The Company has not yet determined which adoption method it will utilize or the effect that the adoption of this guidance will have on its consolidated financial statements.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> In July 2015, the FASB issued ASU 2015-11, &#x201C;Simplifying the Measurement of Inventory,&#x201D; (&#x201C;ASU 2015-11&#x201D;). ASU 2015-11 requires inventory be measured at the lower of cost and net realizable value and options that currently exist for market value be eliminated. ASU 2015-11 defines net realizable value as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective prospectively for reporting periods beginning after December&#xA0;15, 2016 and interim periods within those fiscal years with early adoption permitted. The Company does not expect the adoption of ASU 2015-11 to have a material impact on its consolidated financial statements.</p> </div>
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y10M13D
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-183000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6125000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2055000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-175000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-2955000
us-gaap Operating Income Loss
OperatingIncomeLoss
12336000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2955000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4051000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12229000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
18264000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2114000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11000
us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
125000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
1139000
us-gaap Costs And Expenses
CostsAndExpenses
49752000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000
us-gaap Revenues
Revenues
62088000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2767000
us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
229000
us-gaap Investment Income Net
InvestmentIncomeNet
92000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
62088000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
99000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2114000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-699000
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
us-gaap Net Income Loss
NetIncomeLoss
9080000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
43000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
14090000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1862000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2998000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2671000
us-gaap Interest Expense
InterestExpense
24000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1927000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3449000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
828000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1201000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3149000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
218000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12721000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
0
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-749000
us-gaap Share Based Compensation
ShareBasedCompensation
2668000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18226000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1085000
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
2115000
us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
141000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2119000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
25103000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
927000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4309000
rgen Nonrefundable Upfront Cash Payment Under Collaborations Agreement
NonrefundableUpfrontCashPaymentUnderCollaborationsAgreement
2000000
rgen Long Term Marketable Securities Maturities Term Minimum
LongTermMarketableSecuritiesMaturitiesTermMinimum
P1Y
rgen Increase Decrease In Noncurrent Liabilities
IncreaseDecreaseInNoncurrentLiabilities
-240000
rgen Marketable Securities Remaining Maturity
MarketableSecuritiesRemainingMaturity
P5M15D
rgen Amount To Be Received Upon Completion Of Transfer
AmountToBeReceivedUponCompletionOfTransfer
126000
CY2014Q1 rgen Lease Commencement Date
LeaseCommencementDate
2014-08-01
CY2014Q1 rgen Lease Agreement Term
LeaseAgreementTerm
P8Y1M
CY2014 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.221 pure
CY2014Q1 rgen Non Contingent Consideration Being Recognized As Revenue Over Estimated Period Of Performance
NonContingentConsiderationBeingRecognizedAsRevenueOverEstimatedPeriodOfPerformance
2000000
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
263475 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32677003 shares
CY2014Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.04
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33327377 shares
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2014Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.04
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
650374 shares
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1657000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2216000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2254000
CY2014Q3 us-gaap Revenues
Revenues
15278000
CY2014Q3 us-gaap Investment Income Net
InvestmentIncomeNet
64000
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
15152000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
1466000
CY2014Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1848000
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
34000
CY2014Q3 us-gaap Royalty Revenue
RoyaltyRevenue
126000
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3157000
CY2014Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
15278000
CY2014Q3 us-gaap Interest Expense
InterestExpense
12000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
788000
CY2014Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
10000
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
13062000
CY2014Q3 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
0
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
533000
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4471000
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6931000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1650000
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
163459 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32925004 shares
CY2015Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.310 pure
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33689560 shares
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
764556 shares
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2007000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-38000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3688000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3679000
CY2015Q3 us-gaap Revenues
Revenues
19814000
CY2015Q3 us-gaap Investment Income Net
InvestmentIncomeNet
37000
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
19814000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
2538000
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
65000
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-596000
CY2015Q3 us-gaap Interest Expense
InterestExpense
8000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1141000
CY2015Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
233000
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
16126000
CY2015Q3 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
0
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
981000
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5959000
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8444000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1490000

Files In Submission

Name View Source Status
0001193125-15-368180-index-headers.html Edgar Link pending
0001193125-15-368180-index.html Edgar Link pending
0001193125-15-368180.txt Edgar Link pending
0001193125-15-368180-xbrl.zip Edgar Link pending
d58510d10q.htm Edgar Link pending
d58510dex311.htm Edgar Link pending
d58510dex312.htm Edgar Link pending
d58510dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgen-20150930.xml Edgar Link completed
rgen-20150930.xsd Edgar Link pending
rgen-20150930_cal.xml Edgar Link unprocessable
rgen-20150930_def.xml Edgar Link unprocessable
rgen-20150930_lab.xml Edgar Link unprocessable
rgen-20150930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending